البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
RISPERIDONE
UNIPHARM LTD, ISRAEL
N05AX08
COATED TABLETS
RISPERIDONE 3 MG
PER OS
Required
UNIPHARM LTD, ISRAEL
RISPERIDONE
Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors
2021-05-31
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 The medicine is dispensed with a doctor’s prescription only RISPOND 1, 2, 3, 4 FILM-COATED TABLETS RISPOND SOLUTION COMPOSITION: RISPOND 1 TABLETS: each RISPOND 1 tablet contains: Risperidone 1 mg RISPOND 2 TABLETS: each RISPOND 2 tablet contains: Risperidone 2 mg RISPOND 3 TABLETS: each RISPOND 3 tablet contains: Risperidone 3 mg RISPOND 4 TABLETS: each RISPOND 4 tablet contains: Risperidone 4 mg RISPOND SOLUTION: each 1 ml contains: Risperidone 1 mg Inactive and allergenic ingredients in the preparation – see section 2 “Important information regarding some of the ingredients of the medicine” and section 6 “Further information”. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. This medicine has been prescribed for the treatment of your ailment. Do not pass it on to others. It may harm them, even if it seems to you that their ailment is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? - For the treatment of schizophrenia and symptoms of psychotic disorders. - For treatment of state of mania in bipolar disorder. - For the treatment of psychotic manifestations of moderate to severe Alzheimer’s dementia (short-term treatment up to six weeks in cases of consistent aggression) in patients who are not responding to non-pharmacological treatments and in whom there is concern that they will harm themselves or others. - For long-term treatment in order to maintain the improvement in the state of the illness in patients who have exhibited an initial response. - For the treatment of behavioral disorders such as violence, impulsiveness and self- aggression in children over 5 years of age and in adolescents who are intellectually disabled. THERAPEUTIC GROUP: antipsychotic preparation. Schizophrenia – a condition in which the patient can see or feel things that are not the اقرأ الوثيقة كاملة